SMOLDERING MULTIPLE MYELOMA (SMM)
Clinical trials for SMOLDERING MULTIPLE MYELOMA (SMM) explained in plain language.
Never miss a new study
Get alerted when new SMOLDERING MULTIPLE MYELOMA (SMM) trials appear
Sign up with your email to follow new studies for SMOLDERING MULTIPLE MYELOMA (SMM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to stop precancerous condition from turning into cancer
Prevention OngoingThis study is testing an investigational drug called linvoseltamab in people diagnosed with high-risk smoldering multiple myeloma (SMM), a condition that often progresses to active multiple myeloma. The main goals are to see if the drug is safe and if it can eliminate the abnorma…
Matched conditions: SMOLDERING MULTIPLE MYELOMA (SMM)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Prevention
Last updated Mar 20, 2026 14:47 UTC
-
Scientists hunt for hidden clues to predict deadly blood cancer
Knowledge-focused OngoingThis study aims to understand why some early, symptomless blood conditions progress to a serious bone marrow cancer called multiple myeloma. Researchers will analyze blood, bone marrow, and saliva samples from 60 patients to look for biological markers that signal high risk. The …
Matched conditions: SMOLDERING MULTIPLE MYELOMA (SMM)
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC